Page last updated: 2024-08-24

5-methylcytosine and ER-Negative PR-Negative HER2-Negative Breast Cancer

5-methylcytosine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bao, B; Boerner, JL; Bollig-Fischer, A; Dyson, G; Mitrea, C; Teslow, EA1
Bollig-Fischer, A; Draghici, S; Dyson, G; Kruger, A; Mitrea, C; Ruden, DM; Wijesinghe, P1

Other Studies

2 other study(ies) available for 5-methylcytosine and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Role of TET1 and 5hmC in an Obesity-Linked Pathway Driving Cancer Stem Cells in Triple-Negative Breast Cancer.
    Molecular cancer research : MCR, 2020, Volume: 18, Issue:12

    Topics: 5-Methylcytosine; Animals; Cell Line, Tumor; Diet, High-Fat; Disease Models, Animal; DNA-Binding Proteins; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Hydrogen Peroxide; Mice; Mixed Function Oxygenases; Neoplastic Stem Cells; Obesity; Proto-Oncogene Proteins; Serine-Arginine Splicing Factors; Triple Negative Breast Neoplasms

2020
Integrating 5hmC and gene expression data to infer regulatory mechanisms.
    Bioinformatics (Oxford, England), 2018, 05-01, Volume: 34, Issue:9

    Topics: 5-Methylcytosine; Cell Line, Tumor; Computational Biology; Epigenesis, Genetic; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Sequence Analysis, DNA; Sequence Analysis, RNA; Triple Negative Breast Neoplasms

2018